Morningstar Investor users sign in here.

Video

Year of the Tiger: What's next for Chinese stocks

The Chinese lunar year is almost over, and what a ride it's been. Morningstar speaks to JPMorgan Asset Management strategist Mike Bell about what's ahead. 

Mentioned: Alibaba Group Holding Ltd (BABA)


Lukas Strobl: It's a few days until the Chinese New Year, ending a year that many investors will want to forget. Alibaba has lost half its value and mainland-listed stocks are teetering near bear market territory after a series of regulatory crackdowns and a property finance crisis. Here to discuss with me whether the year of the Tiger is looking any better is JPMorgan Asset Management's Global Market Strategist, Mike Bell.

Mike, where are Chinese stocks headed next? 

Mike Bell: So, we actually think the next couple of years are probably going to be pretty strong for Chinese equities. If you look over since 2010, there have been four occasions on which MSCI China has gone down by more than 30%, including the most recent one. On the prior three occasions. once Chinese stocks had fallen 30%, they were always higher a year later, and two years later, they were a minimum of 25% higher, and on the other two occasions, they were more than 40% higher two years after they had fallen by 30%. Now, of course, the past is not always a perfect guide to the future. But that does suggest to us that it's probably not a good time to be selling Chinese stocks and that the likelihood is, we'll probably see strong returns over the next couple of years.

Strobl: Now, the past year's correction has put a damper on some of these stretched valuations. What defines Chinese stocks that are most likely to outperform from here on?

Bell: Yeah. So, you're right that valuations have come down a lot. Valuations for China were on about 18.5 times forward earnings back in February of last year. They've now come down to only 12 times on the P/E ratio, so looking much more reasonably valued. That compares with the U.S. where the S&P 500 is on a P/E of about 19.5 times earnings. So, China is significantly cheaper than the U.S. despite the fact that we think that Chinese growth is going to be more than twice as strong as U.S. growth over the next decade. In terms of earnings, consensus is forecasting around 15% earnings growth both for 2022 and 2023. So, even if valuations stay at these relatively low levels, that should support Chinese stocks over the next couple of years.

Looking at which sectors are likely to do well, we think the consumer is an area that's very exciting. The middle class is expected to grow by about a third of a billion people by 2030. That's as many people as live in the whole of the United States. And so, as their incomes rise and consumption grows, we think that will benefit consumer-facing stocks. We also think that in the tech sector, things like industrial automation, semiconductors and some software companies look attractive. And then, finally, we think there are attractive opportunities in the healthcare sector.

Strobl: Now, last year, there have been crackdowns on education, Chinese big tech. There was the Evergrande fiasco. Those were shocks that few could have seen coming. What kinds of wildcards should we be on the lookout for next?

Bell: Yeah. So, as you say, last year was indeed a difficult year, largely because we saw a significant slowdown in the pace of credit growth in China. Now, the good news this year is it looks like credit growth is actually stabilizing in China, and whereas in the West, it seems like we're going to see tighter monetary policy. In China, they're actually going in the opposite direction and easing monetary policy so that that stimulus could actually produce a bit of a positive surprise relative to what some people expect at the moment.

The other risks out there, I think, are Omicron. China has so far done incredibly well at containing COVID over the last few years with their zero COVID policy. Omicron, of course, is much more transmissible than previous variants, and so, there's a risk that were that to get out, it could spread pretty quickly through the population. But that speed of transmissibility is also a reason we think that if it did, even in that worst-case scenario, spread very rapidly through the population, it would likely only be a relatively brief pit to economic activity and then growth would resume after that.

So, I think, overall, if we look at the outlook for China over the next couple of years, we see that valuations have come down quite a lot, the authorities are stimulating now, whereas last year you saw tighter policy, and the combination of those cheaper valuations plus some stimulus suggests to us that the outlook over the next couple of years should be pretty strong for Chinese equities.

Strobl: So, a Happy New Year indeed. Thank you for joining us, Mike. For Morningstar, I'm Lukas Strobl.



© 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.

More from Morningstar

Bank results: the winners and losers
Video

Bank results: the winners and losers

Morningstar analyst Nathan Zaia explains how the banks did and what the future holds.
How to deal with financial stress
Video

How to deal with financial stress

More high-income earners are now also experiencing financial stress. We go through practical ways to reduce it
UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead
Video

UniSuper CIO John Pearce on why the 60/40 portfolio is far from dead

The $130 Billion SuperFund Manager also talks about how he sees risk, his recent investments, and why history isn’t a good guide to the future.
Incitec Pivot: explosive upside ahead?
Video

Incitec Pivot: explosive upside ahead?

Morningstar analyst Mark Taylor believes imminent growth in explosives earnings could lift sentiment.
Why Morningstar see opportunities in coal stocks
Video

Why Morningstar see opportunities in coal stocks

Analyst Jon Mills explains why he’s recently increased fair value estimates for Australian coal companies.
Is the sharp fall in ResMed's share price justified?
Video

Is the sharp fall in ResMed's share price justified?

The potential for weight loss drugs to impact the sleep apnea giant has weighed on the share price, though Morningstar analyst Shane Ponraj thinks...